The Latest Cardiac and Vascular News
U.S. FDA has assigned a target action date of June 16, 2023 Application based on results from the Phase 3 VALOR-HCM study PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental new drug application (sNDA) for CAMZYOS® (mavacamten) for an […]
MT. OLIVE, N.J. & CARLSBAD, Calif.–(BUSINESS WIRE)–Catheter Precision, Inc. (“Catheter Precision”), a medical device company focused on cardiac electrophysiology, announces receipt of three commercial orders in the past 60 days as usage of the device continues to increase in the U.S. On September 12, 2022 privately held Catheter Precision announced […]
Southlake, Texas, Oct. 20, 2022 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of AI, today announced it was recognized by MedTech Outlook […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD) announces the U.S. Food and Drug Administration (FDA) has accepted and closed the post-approval study reports related to the pre-market approvals (PMA) for Impella heart pumps. The FDA’s action is another affirmation that Impella heart pumps are safe and effective for cardiogenic shock, high-risk PCI, post-cardiotomy cardiogenic […]
The Endologix ALTO Stent Graft System treats abdominal aortic aneurysms (AAA) with a success rate of 96.7% at 12 months as observed in ELEVATE IDE Study IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company dedicated to improving patients’ lives by providing disruptive therapies for the interventional treatment […]
Industry Leader Chentelle Lane Joins as COO; Company Partners to Power Leading Cardiology Networks in Southwest ALBUQUERQUE, N.M., Oct. 19, 2022 /PRNewswire/ — Karoo Health, the leader in end-to-end, tech-enabled, value-based cardiac care, announced today the hiring of industry veteran Chentelle Lane as COO. Lane will help guide the company’s business and operating strategy, including […]
ST. LOUIS PARK, Minn., Oct. 19, 2022 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company, is leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation with more than a decade of commercial experience in treating over 1,800 patients globally with the transapical […]
Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including HeartSciences’ MyoVista SOUTHLAKE, Texas, Oct. 19, 2022 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making […]
The two leading innovative companies have announced a landmark agreement to equip Mawi’s new cardiac monitoring watch with AccurKardia’s automated ECG analytics NEW YORK & LONDON–(BUSINESS WIRE)–AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocardiogram (ECG) analytics, announced today it will collaborate with Mawi, a medtech provider of medical […]
This approach may be a paradigm shift in patient care PITTSBURGH–(BUSINESS WIRE)–Vivasc Therapeutics Inc. is pleased to announce it has initiated its second NIH Phase I STTR research grant (Award Number R41HL164212), in conjunction with Georgetown University. This work is supported by the NIH National Heart, Lung, and Blood Institute, […]
